Oxytocin Should Be Discontinued When Shoulder Dystocia Occurs
Yes, continuing oxytocin infusion during shoulder dystocia can make relief attempts more difficult and should be stopped immediately. The ongoing uterine contractions induced by oxytocin can maintain the impaction of the anterior shoulder against the maternal symphysis pubis, working directly against the manual maneuvers being performed to relieve the dystocia.
Physiologic Rationale
When shoulder dystocia occurs, the anterior fetal shoulder is trapped behind the maternal pubic symphysis. Continued uterine contractions from oxytocin infusion:
- Maintain downward pressure on the impacted shoulder, preventing the rotational and manipulative maneuvers from being effective
- Work against the clinician's attempts to create space and reposition the fetus
- Increase the risk of brachial plexus injury by maintaining compression forces on the fetal neck and shoulder girdle during manipulation attempts
The FDA label for oxytocin explicitly states that "the infusion can be abruptly stopped, and oxytocic stimulation of the uterine musculature will soon wane" 1. This rapid reversibility is a critical safety feature that should be utilized immediately when shoulder dystocia is recognized.
Evidence-Based Management
The 2022 French guidelines for urgent obstetric situations specifically address oxytocin timing, recommending administration "at the time of shoulder release or immediate postpartum" 2. This timing is deliberate—oxytocin is given after the shoulders are delivered, not during their delivery, to avoid the exact complication you're asking about.
Key Clinical Actions When Shoulder Dystocia Occurs:
- Immediately stop the oxytocin infusion if it is running
- Call for help and announce the dystocia clearly
- Initiate McRoberts maneuver as first-line intervention 2
- Apply suprapubic pressure (never fundal pressure, which worsens impaction)
- Proceed through sequential maneuvers without the interference of ongoing contractions
Supporting Evidence on Oxytocin and Dystocia
Research demonstrates that oxytocin use is associated with increased risk of shoulder dystocia complications. A 2005 study of extreme macrosomia found that "shoulder dystocia was associated with use of oxytocin and instrumental deliveries," and suggested that "a policy eliminating the use of oxytocin and instrumental deliveries would have prevented most birth traumas in this group" 3. While this refers to oxytocin use during labor progression, the principle extends to the actual dystocia event—ongoing uterine stimulation compounds the mechanical problem.
A 1993 analysis of 185 shoulder dystocia cases found that while oxytocin use during labor was not a predictor of dystocia occurrence, the study emphasized that "no protocol should serve to substitute for clinical judgment" 4. The clinical judgment here is clear: when dystocia occurs, remove all factors that maintain uterine contractility and shoulder impaction.
Critical Distinction
It's important to distinguish between:
- Oxytocin use during labor (which may or may not increase dystocia risk, evidence is mixed 5, 3, 4)
- Continuing oxytocin during active shoulder dystocia (which mechanically impedes resolution and should be stopped)
The 2023 expert opinion on active phase labor notes that "uterotonic stimulation is inadvisable lest unsafe uterine hyperstimulation occurs" in certain high-risk situations 6. Shoulder dystocia represents the ultimate high-risk situation where uterine activity works against safe delivery.
Practical Implementation
The moment shoulder dystocia is recognized:
- Verbally announce "shoulder dystocia" to the team
- Have someone immediately stop the oxytocin infusion
- The rapid offset of oxytocin's effects (within minutes) allows uterine relaxation
- This relaxation provides the mechanical space needed for successful maneuvers
The 2024 comprehensive review on shoulder dystocia emphasizes the importance of "a preplanned sequence of maneuvers" 7, and stopping oxytocin should be part of this standardized response.
Bottom line: Oxytocin infusion during shoulder dystocia maintains the mechanical impaction that defines the emergency. Stop it immediately to optimize the effectiveness of relief maneuvers and minimize the risk of permanent brachial plexus injury.